Accord Healthcare, Inc.
Accord Healthcare, Inc. appears in FDA public data with 106 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0777-2026, Class II) was initiated on August 6, 2026.
Summary
- Total Recalls
- 106 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 0
Known Names
accord healthcare, accord healthcare, inc
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0777-2026 | Class II | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: | August 6, 2026 |
| D-0781-2026 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for | August 6, 2026 |
| D-0784-2026 | Class II | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45 | August 6, 2026 |
| D-0775-2026 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: | August 6, 2026 |
| D-0776-2026 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: | August 6, 2026 |
| D-0785-2026 | Class II | Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457 | August 6, 2026 |
| D-0783-2026 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: | August 6, 2026 |
| D-0782-2026 | Class II | Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-45 | August 6, 2026 |
| D-0780-2026 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for | August 6, 2026 |
| D-0779-2026 | Class II | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451- | August 6, 2026 |
| D-0786-2026 | Class II | Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Ac | August 6, 2026 |
| D-0778-2026 | Class II | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: | August 6, 2026 |
| D-0656-2026 | Class II | Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: A | June 8, 2026 |
| D-0006-2026 | Class II | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured f | September 16, 2025 |
| D-0522-2025 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured for: | June 20, 2025 |
| D-0521-2025 | Class II | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: A | June 20, 2025 |
| D-0518-2025 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for: Ac | June 20, 2025 |
| D-0524-2025 | Class II | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: | June 20, 2025 |
| D-0520-2025 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 90-count bottle, Rx Only, Manufactured for: Acc | June 20, 2025 |
| D-0523-2025 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: | June 20, 2025 |